1
|
Bousser MG and Ferro JM: Cerebral venous
thrombosis: An update. Lancet Neurol. 6:162–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Stam J: Thrombosis of the cerebral veins
and sinuses. N Engl J Med. 352:1791–1798. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Einhäupl K, Stam J, Bousser MG, De Bruijn
SF, Ferro JM, Martinelli I and Masuhr F; European Federation of
Neurological Societies: EFNS guideline on the treatment of cerebral
venous and sinus thrombosis in adult patients. Eur J Neurol.
17:1229–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ilyas A, Chen CJ, Raper DM, Ding D, Buell
T, Mastorakos P and Liu KC: Endovascular mechanical thrombectomy
for cerebral venous sinus thrombosis: A systematic review. J
Neurointerv Surg. 9:1086–1092. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
van den Berg LA, Dijkgraaf MG, Berkhemer
OA, Fransen PS, Beumer D, Lingsma HF, Majoie CB, Dippel DW, van der
Lugt A, van Oostenbrugge RJ, et al: Two-year outcome after
endovascular treatment for acute ischemic stroke. N Engl J Med.
376:1341–1349. 2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kim ID, Shin JH, Kim SW, Choi S, Ahn J,
Han PL, Park JS and Lee JK: Intranasal delivery of HMGB1 siRNA
confers target gene knockdown and robust neuroprotection in the
postischemic brain. Mol Ther. 20:829–839. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Manns MP, Wedemeyer H, Singer A,
Khomutjanskaja N, Dienes HP, Roskams T, Goldin R and Hehnke U:
Glycyrrhizin in patients who failed previous interferon alpha-based
therapies: Biochemical and histological effects after 52 weeks. J
Viral Hepat. 19:537–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kim SW, Jin Y, Shin JH, Kim ID, Lee HK,
Park S, Han PL and Lee JK: Glycyrrhizic acid affords robust
neuroprotection in the postischemic brain via anti-inflammatory
effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiol
Dis. 46:147–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wu CX, He LX, Guo H, Tian XX, Liu Q and
Sun H: Inhibition effect of glycyrrhizin in
lipopolysaccharide-induced high-mobility group box 1 releasing and
expression from RAW264.7 cells. Shock. 43:412–421. 2015. View Article : Google Scholar
|
10
|
Zhang J, Wu Y, Weng Z, Zhou T, Feng T and
Lin Y: Glycyrrhizin protects brain against ischemia-reperfusion
injury in mice through HMGB1 TLR4-IL-17A signaling pathway. Brain
Res. 1582:176–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Gong G, Xiang L, Yuan L, Hu L, Wu W, Cai
L, Yin L and Dong H: Protective effect of glycyrrhizin, a direct
HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced
inflammation, oxidative stress, and apoptosis in rats. PLoS One.
9:pp. e894502014, View Article : Google Scholar : PubMed/NCBI
|
12
|
Srivastava AK, Gupta RK, Haris M, Ray M,
Kalita J and Misra UK: Cerebral venous sinus thrombosis: Developing
an experimental model. J Neurosci Methods. 161:220–222. 2007.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M
and Chopp M: Therapeutic benefit of intravenous administration of
bone marrow stromal cells after cerebral ischemia in rats. Stroke.
32:1005–1011. 2001. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ansari S, Azari H, McConnell DJ, Afzal A
and Mocco J: Intraluminal middle cerebral artery occlusion (MCAO)
model for ischemic stroke with laser doppler flowmetry guidance in
mice. J Vis Exp: pii. 2879:2011.
|
15
|
Chen C, Wang Q, Gao Y, Lu Z, Cui X, Zheng
T, Liu Y, Li X, He X, Zhang X, et al: Photothrombosis combined with
thrombin injection establishes a rat model of cerebral venous sinus
thrombosis. Neuroscience. 306:39–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gu JJ, Chen JB, Zhang JH, Zhang H and Wang
SS: Recombinant human soluble thrombomodulin protects against brain
injury in a CVST rat model, via downregulation of the HMGB1-RAGE
axis. Mol Med Rep. 14:5217–5222. 2016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sohun M and Shen H: The implication and
potential applications of high-mobility group box1 protein in
breast cancer. Ann Transl Med. 4:2172016. View Article : Google Scholar
|
18
|
Anggayasti WL, Mancera RL, Bottomley S and
Helmerhorst E: The self-association of HMGB1 and its possible role
in the binding to DNA and cell membrane receptors. FEBS Lett.
591:282–294. 2017. View Article : Google Scholar
|
19
|
Schaller B and Graf R: Cerebral ischemia
and reperfusion: The pathophysiologic concept as a basis for
clinical therapy. J Cereb Blood Flow Metab. 24:351–371. 2004.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Goyal M, Menon BK, van Zwam WH, Dippel DW,
Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de
Miquel MA, et al: Endovascular thrombectomy after large-vessel
ischaemic stroke: A meta-analysis of individual patient data from
five randomised trials. Lancet. 387:1723–1731. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Alegiani AC, Dorn F, Herzberg M,
Wollenweber FA, Kellert L, Siebert E, Nolte CH, von Rennenberg R,
Hattingen E, Petzold GC, et al: Systematic evaluation of stroke
thrombectomy in clinical practice: The German stroke registry
endovascular treatment. Int J Stroke. Oct 22–2018, Epub ahead of
print. PubMed/NCBI
|
22
|
Mizuma A and Yenari MA: Anti-inflammatory
targets for the treatment of reperfusion injury in stroke. Front
Neurol. 8:4672017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Bertheloot D and Latz E: HMGB1, IL-1alpha,
IL-33 and S100 proteins: Dual-function alarmins. Cell Mol Immunol.
14:43–64. 2017. View Article : Google Scholar
|
24
|
Andersson U, Yang H and Harris H:
High-mobility group box1 protein (HMGB1) operates as an alarmin
outside as well as inside cells. Semin Immunol. 38:40–48. 2018.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Bai J and Lyden PD: Revisiting cerebral
postischemic reperfusion injury: New insights in understanding
reperfusion failure, hemorrhage, and edema. Int J Stroke.
10:143–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Mollica L, De Marchis F, Spitaleri A,
Dallacosta C, Pennacchini D, Zamai M, Agresti A, Trisciuoglio L,
Musco G and Bianchi ME: Glycyrrhizin binds to high-mobility group
box1 protein and inhibits its cytokine activities. Chem Biol.
14:431–441. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Ieong C, Sun H, Wang Q and Ma J:
Glycyrrhizin suppresses the expressions of HMGB1 and ameliorates
inflammative effect after acute subarachnoid hemorrhage in rat
model. J Clin Neurosci. 47:278–284. 2018. View Article : Google Scholar
|
28
|
Jadhav RS, Ahmed L, Swamy PL and Sanaullah
S: Neuroprotective effects of polyhydroxy pregnane glycoside
isolated from Wattakaka volubilis (L.f.) Stapf. after middle
cerebral artery occlusion and reperfusion in rats Brain Res.
1515:78–87. 2013.
|
29
|
Zheng YQ, Liu JX, Wang JN and Xu L:
Effects of crocin on reperfusion-induced oxidative/nitrative injury
to cerebral microvessels after global cerebral ischemia. Brain Res.
1138:86–94. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liu H, Li J, Zhao F, Wang H, Qu Y and Mu
D: Nitric oxide synthase in hypoxic or ischemic brain injury. Rev
Neurosci. 26:105–117. 2015. View Article : Google Scholar : PubMed/NCBI
|